Form 4 for GRDX GridAI Technologies Corp.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001104659-24-036143 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-19 | 2024-03-15 | GRDX | SAPIRSTEIN JAMES | COB, CEO, Dir | S - Sale | $4.96 | -1,887 | 37.3K | -5% | -$9,360 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | S | D | 1,887 | $4.96 | 37,279 | D | — | — | (F2) The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.90 - $5.175, inclusive. The Reporting Person undertakes to provide First Wave BioPharma, Inc. ("First Wave"), any security holder of First Wave, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. (F3) Includes unvested RSUs. |